Julie Clark, Chief Medical Officer at Adverum Biotechnologies, Inc. (ADVM), sold 4,766 shares at $2.17 ($10K) on 2021-09-30, disclosed to the SEC on 2021-10-04.
Open-market sale of $10k ADVM by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.